# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Robert Moskow maintains Freshpet (NASDAQ:FRPT) with a Buy and raises the price target from $128 to $143.
Wells Fargo analyst Marc Torrente maintains Freshpet (NASDAQ:FRPT) with a Overweight and raises the price target from $124 t...
DA Davidson analyst Brian Holland maintains Freshpet (NASDAQ:FRPT) with a Buy and raises the price target from $138 to $153.
Oppenheimer analyst Rupesh Parikh maintains Freshpet (NASDAQ:FRPT) with a Outperform and raises the price target from $120 t...
Baird analyst Peter Benedict maintains Freshpet (NASDAQ:FRPT) with a Outperform and raises the price target from $125 to $135.
The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during mid...
Freshpet Inc surges on solid Q1 FY24 earnings, beating sales estimates with a 33.6% YoY growth to $223.85 million. Gross profit...
EYPT: -42% | EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not m...